Company / Total Assets
Catalyst Pharmaceuticals Partners, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.1B
FY2025
5-year range
$237.8M / $1.1B
FY2021-FY2025
Trend
+29.7%
vs FY2024
Sector context
#77 of 214
Health Care
What the data says
At $1.1B, Catalyst Pharmaceuticals Partners, Inc.'s total assets ranks #77 of 214 in the Health Care sector. Total Assets has increased for 7 consecutive years, from $60M in FY2018 to $1.1B in FY2025.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of +41.8%.
Improved from $470M to $1.1B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +43.2%
- 5-Year CAGR
- +41.8%
- 10-Year CAGR
- -
Sector benchmark
#77 of 214 in Health CareTop 36% of 214This company $1.1B Sector average $7.5B
▼
-85.2% below sector average
Key checks
Key Insights
- Catalyst Pharmaceuticals Partners, Inc.'s total assets has grown for 7 consecutive years.
- 5-year CAGR of +41.8%, indicating consistent growth.
- In FY2025, total assets increased 29.7% year-over-year.
- Ranks #77 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | +29.7% |
| FY2024 | $851.4M | +81.1% |
| FY2023 | $470.1M | +25.2% |
| FY2022 | $375.6M | +58.0% |
| FY2021 | $237.8M | +23.6% |
| FY2020 | $192.4M | +71.2% |
| FY2019 | $112.4M | +85.9% |
| FY2018 | $60.4M | -29.2% |
| FY2017 | $85.4M | +104.7% |
| FY2016 | $41.7M | -30.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026